Takeda sold Xiidra to Novartis for $3.4 billion upfront and up to an additional $1.9 billion in potential milestone receipts.
Read More
The capital raise will accelerate Piramal Pharma's organic and inorganic growth plans,
Read More
J&J has partnered with the U.S. government on a $1 billion investment to speed development and production of its vaccine, even before it's proven to work.
Read More
CEPI has deployed up to $829 million so far in the search for a COVID-19 vaccine through partnerships with nine developers, with the hope that at least some will be successful.
Read More
Fellow Indian drug firm Cipla Ltd had said on Tuesday that its own version of the antiviral drug remdesivir would be priced below Rs 5,000
Read More
India has approved the generic versions made by Cipla and Hetero for restricted emergency use in severe COVID-19 cases.
Read More
Inovio said a previous version of the device has been used in clinical trials to safely dose more than 2,000 patients
Read More
The expectations suggest sales of between $2 billion and $3 billion between 2020 and 2021 at a price of $1,000 to $2,000 per course, according to Jefferies analyst Michael Yee.
Read More
